Impact of hydroxychloroquine used as DMARD on SARS-CoV-2 tests and infection evolution in a population of 871 patients with inflammatory rheumatic and musculoskeletal diseases.
Saved in:
| Title: | Impact of hydroxychloroquine used as DMARD on SARS-CoV-2 tests and infection evolution in a population of 871 patients with inflammatory rheumatic and musculoskeletal diseases. |
|---|---|
| Authors: | Trefond, Ludovic1 (AUTHOR) ltrefond@chu-clermontferrand.fr, Drumez, Elodie2 (AUTHOR), Andre, Marc1 (AUTHOR), Costedoat-Chalumeau, Nathalie3 (AUTHOR), Seror, Raphaèle4 (AUTHOR), Devaux, Mathilde5 (AUTHOR), Dernis, Emmanuelle6 (AUTHOR), Dieudonné, Yannick7 (AUTHOR), El Mahou, Soumaya8 (AUTHOR), Lanteri, Aurelia9 (AUTHOR), Melki, Isabelle10 (AUTHOR), Queyrel, Viviane11 (AUTHOR), Roumier, Mathilde12 (AUTHOR), Schmidt, Jean13 (AUTHOR), Barnetche, Thomas14 (AUTHOR), Thomas, Thierry15 (AUTHOR), Cacoub, Patrice16,17,18,19 (AUTHOR), Belot, Alexandre20 (AUTHOR), Aumaitre, Olivier1 (AUTHOR), Richez, Christophe14 (AUTHOR) |
| Source: | Joint Bone Spine. Dec2021, Vol. 88 Issue 6, pN.PAG-N.PAG. 1p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
